Education
About Us
Working with TipRanks
Follow Us
Noah Rosenberg Insider Profile
4 Followers
Noah Rosenberg, CMO at Esperion, holds 0.00 shares in Esperion (Ticker: ESPR), holds 2.36K shares in Verrica Pharmaceuticals (Ticker: VRCA), holds 47.61K shares in Travere Therapeutics (Ticker: TVTX). Most recently, Noah Rosenberg ― shares of Esperion on ― for an estimated value of ―.
Noah Rosenberg has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Noah Rosenberg holds in companies
Most Profitable Insider Trade
The most profitable trade made by Noah Rosenberg
Noah Rosenberg's Trading History
Esperion
―
CMO
―
$0.00
Travere Therapeutics
Aug 17, 2021
CMO
Uninformative Buy
―
$1.66M
Verrica Pharmaceuticals
Nov 25, 2025
CMO
Informative Buy
9.99K
$18.67K
List of latest transactions for each holding click on a transaction to see Noah Rosenberg's performance on stock
You May Also Like
Noah Rosenberg insider profile FAQ
What is the percentage of profitable transactions made by Noah Rosenberg?
The percentage of profitable transactions made by Noah Rosenberg is ―.
What is the average return per transaction made by Noah Rosenberg?
The average return per transaction made by Noah Rosenberg is ―.
What stocks does Noah Rosenberg hold?
Noah Rosenberg holds: ESPR, TVTX, VRCA stocks.
What was Noah Rosenberg’s latest transaction?
Noah Rosenberg latest transaction was an Uninformative Buy of ―.
What was Noah Rosenberg's most profitable transaction?
Noah Rosenberg’s most profitable transaction was an Informative Buy of VRCA stock on November 25, 2025. The return on the trade was 72.00%.
What is Noah Rosenberg's role in Esperion?
Noah Rosenberg's role in Esperion is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.